Goto

Collaborating Authors

 treatment goal


An ExplainableFair Framework for Prediction of Substance Use Disorder Treatment Completion

Lucas, Mary M., Wang, Xiaoyang, Chang, Chia-Hsuan, Yang, Christopher C., Braughton, Jacqueline E., Ngo, Quyen M.

arXiv.org Artificial Intelligence

Fairness of machine learning models in healthcare has drawn increasing attention from clinicians, researchers, and even at the highest level of government. On the other hand, the importance of developing and deploying interpretable or explainable models has been demonstrated, and is essential to increasing the trustworthiness and likelihood of adoption of these models. The objective of this study was to develop and implement a framework for addressing both these issues - fairness and explainability. We propose an explainable fairness framework, first developing a model with optimized performance, and then using an in-processing approach to mitigate model biases relative to the sensitive attributes of race and sex. We then explore and visualize explanations of the model changes that lead to the fairness enhancement process through exploring the changes in importance of features. Our resulting-fairness enhanced models retain high sensitivity with improved fairness and explanations of the fairness-enhancement that may provide helpful insights for healthcare providers to guide clinical decision-making and resource allocation.


GOTM: a Goal-Oriented Framework for Capturing Uncertainty of Medical Treatments

Mougouei, Davoud, Powers, David

arXiv.org Artificial Intelligence

It has been widely recognized that uncertainty is an inevitable aspect of diagnosis and treatment of medical disorders. Such uncertainties hence, need to be considered in computerized medical models. The existing medical modeling techniques however, have mainly focused on capturing uncertainty associated with diagnosis of medical disorders while ignoring uncertainty of treatments. To tackle this issue, we have proposed using a fuzzy-based modeling and description technique for capturing uncertainties in treatment plans. We have further contributed a formal framework which allows for goal-oriented modeling and analysis of medical treatments.


Case Representation and Similarity Modeling for Non-Specific Musculoskeletal Disorders - a Case-Based Reasoning Approach

Jaiswal, Amar (Norwegian University of Science and Technology) | Bach, Kerstin (Norwegian University of Science and Technology) | Meisingset, Ingebrigt (Norwegian University of Science and Technology) | Vasseljen, Ottar (Norwegian University of Science and Technology)

AAAI Conferences

This paper presents a case-based reasoning (CBR) application for discovering similar patients with non-specific musculoskeletal disorders (MSDs) and recommending treatment plans using previous experiences. From a medical perspective, MSD is a complex disorder as its cause is often bounded to a combination of physiological and psychological factors. Likewise, the features describing the condition and outcome measures vary throughout studies. However, healthcare professionals in the field work in an experience-based way, therefore we chose CBR as the core methodology for developing a decision support system for physiotherapists which would assist them in the process of their co-decision making and treatment planning. In this paper, we focus on case representation and similarity modeling for the non-specific MSD patient data as well as we conducted initial experiments on comparing patient profiles.


RCM Answers - Using AI to Reduce Prior Authorization Burden in Healthcare

#artificialintelligence

One of the most frustrating elements of the current healthcare environment is the administrative burden of prior authorizations for medications and procedures. It is a frustration for providers, for patients, and for payers. Is there any way to solve this dilemma? For physicians, an estimated 20 hours per week is spent in prior authorization activities, costing an average of 83,000 in excess annual overhead per physician. Is there an actual benefit for this effort? Most physicians say that payers (commercial, Medicare, Medicaid, and pharmacy benefit managers (PBMs)) use prior authorizations to keep costs down.


Using AI to reduce prior authorization burden in healthcare

#artificialintelligence

One of the most frustrating elements of the current healthcare environment is the administrative burden of prior authorizations for medications and procedures. It is a frustration for providers, for patients, and for payers. Is there any way to solve this dilemma? For physicians, an estimated 20 hours per week is spent in prior authorization activities, costing an average of 83,000 in excess annual overhead per physician. Is there an actual benefit for this effort? Most physicians say that payers (commercial, Medicare, Medicaid, and pharmacy benefit managers (PBMs)) use prior authorizations to keep costs down.